Product
Eszopiclone
Aliases
Lunesta
7 clinical trials
6 indications
Indication
InsomniaIndication
Obstructive Sleep ApneaIndication
Sleep ApneaIndication
ObstructiveIndication
Sleep DisorderIndication
obstructive sleep apneaClinical trial
Risks for Transition From Therapeutic Hypnotic Use to AbuseStatus: Completed, Estimated PCD: 2022-02-22
Clinical trial
Endotypic Traits and Obstructive Sleep Apnea SurgeryStatus: Recruiting, Estimated PCD: 2027-08-31
Clinical trial
Effect of Eszopiclone on Adherence to Continuous Positive Airway Pressure (CPAP) and Severity of Insomnia in Patients With Comorbidity Between Insomnia and Obstructive Sleep Apnea (COMISA)Status: Recruiting, Estimated PCD: 2025-03-20
Clinical trial
Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP): a Pilot TrialStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
Do Endotypes Predict Response and Sequelae in OSA PatientsStatus: Recruiting, Estimated PCD: 2027-01-01
Clinical trial
Comparative Study on the Cognitive Function and Brain Imaging of Modified Suanzaoren Decoction and Eszopiclone in the Treatment of Primary Insomnia Patients With Yin Deficiency and Hyperactivity of Fire SyndromeStatus: Completed, Estimated PCD: 2023-10-31
Clinical trial
Rescuing OSA Patients Unable to Tolerate CPAP Using Endotype-Targeted Combination Drug Therapy: a Randomized, Double-Blind, Placebo-Controlled TrialStatus: Completed, Estimated PCD: 2022-01-27